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Abstract: In this retrospective study we did a comparative analysis of the outcome of 28
+1 
to 32
+0 weeks gestation babies between the State of Qatar and some high income countries 
with an objective of providing an evidence base for improving the survival of preterm 
neonates in low income countries. Data covering a five year period (2002–2006) was 
ascertained on a pre-designed Performa. A comparative analysis with the most recent data 
from VON, NICHD, UK, France and Europe was undertaken. Qatar’s 28
+1 to 32
+0 weeks 
Prematurity Rate (9.23 per 1,000 births) was less than the UK’s (p < 0.0001). Of the 597 
babies born at 28
+1  to 32
+0  weeks of gestation, 37.5% did not require any respiratory 
support, while 31.1% required only CPAP therapy. 80.12% of the MV and 96.28% of 
CPAP therapy was required for <96 hours. 86.1% of the mothers had received antenatal 
steroids. The 28
+1 to 32
+0 weeks mortality rate was 65.3/1,000 births with 30.77% deaths 
attributable to a range of lethal congenital and chromosomal anomalies. The survival rate 
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increased with increasing gestational age (p < 0.001) and was comparable to some high 
income countries. The incidence of in hospital pre discharge morbidities in Qatar (CLD 
2.68%, IVH Grade III 0.84%, IVH Grade IV 0.5%, Cystic PVL 0.5%) was less as 
compared to some high income countries except ROP ≥ Stage 3 (5.69%), which was higher 
in Qatar. The incidence  of symptomatic PDA, NEC and severe ROP decreased with 
increasing gestational age (p < 0.05). We conclude that the mortality and in hospital pre 
discharge morbidity outcome of 28
+1 to 32
+0 weeks babies in Qatar are comparable with 
some high income countries. In two thirds of this group of preterm babies, the immediate 
postnatal respiratory distress can be effectively managed by using two facility based cost 
effective interventions; antenatal steroids and postnatal CPAP. This finding is very 
supportive to the efforts of international perinatal health care planners in designing facility-
based cost effective options for low income countries. 
Keywords:  epidemiology;  gestational  age; mortality; morbidity; Qatar; developing 
countries 
Abbreviations:  CLD: Chronic Lung Disease; NEC: Necrotizing Enterocolitis; PDA: 
Patent Ductus Arteriosus; IVH: Intra Ventricular Hemorrhage; PVL: Periventricular 
Leukomalacia;  ROP: Retinopathy of Prematurity; MV: Mechanical Ventilation; CPAP: 
Continuous Positive Airway Pressure; VON: Vermont Oxford Network; NICHD: National 
Institute of Child Health and Human Development  
 
1. Introduction 
Very Preterm Babies (≤32 weeks of gestation) constitute 1–2% of all live births in high income 
countries,  but account for at least one third of perinatal mortality, the majority of neonatal   
mortality [1-5], as well as both short-term [5] (pre discharge, in hospital) and long-term (at two years 
corrected age) morbidity [6-9]. Although neonatal mortality and morbidity are known to worsen with 
decreasing gestational age and weight at birth [1-9], the dramatic improvement in the intact survival of 
preterm babies has been one of the most remarkable features of neonatology in high income countries 
over the last three decades [9]. Correspondingly, the question of how ‘small is small’ has, over the last 
two decades, gradually decreased in terms of gestation period from 32 weeks to 28 weeks and then  
24 weeks; and in terms of birth weight from 1,500 g to 1,000 g, to 800 g and then 500 g [10-15]. 
However, the long term outcomes, the cost of care of babies born ≤28 weeks (particularly ≤26 weeks) 
and/or birth weight ≤1,000 g (and particularly ≤750 g), and the futility of intervention at the edge of 
viability remains a hot debate, even among the most resource rich countries [10-15] and the care of 
extremely premature babies (≤28 weeks and ≤ 1,000 g at birth) is not an option for resource restricted 
developing countries. Instead these countries should focus on babies born ≥28 weeks gestation and  
≥1,000 g at birth. Over the last decade the intact survival of this group of preterm babies has risen to a 
level which has put to rest any major controversy concerning cost effectiveness [10]. In fact by the Int. J. Environ. Res. Public Health 2010, 7                 
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1990s almost all NICUs in the high income countries had achieved  ≥ 90% survival of babies with a 
birth weight of >1,000 g [10]. 
The world’s nations are divided in providing equity in newborn care [16] and the global picture of 
newborn care and outcomes presents an unfortunate contrast on both sides of the divide between high 
income countries versus  low income countries  [16-19]. The scenario and challenges of neonatal 
survival are unique in low income countries burdened by very high neonatal mortality [16]  and 
socioeconomic and political constraints [17]. Worldwide some 12.9 million babies are born preterm 
each year; of which 1.12 million die each year (28% of 4 million global neonatal deaths; 98% of which 
occur in low income countries) [18]. The very high cost and highly technology dependent care of 
extremely premature babies (<28 weeks and <1,000 g at birth) is neither a viable nor a sustainable 
option for low income countries. Therefore UNICEF’s Annual Global Child Survival Reports exclude 
babies <1,000 g from the mortality data published for low income countries [19]. These countries 
might be better off investing their limited resources in the care of full term and bigger preterm babies, 
the majority of which die of potentially preventable diseases [16]. Indeed some developing countries 
e.g., Sri Lanka, Indonesia, Moldova, Nicaragua, Vietnam and Honduras have, within their limited 
resources and without resorting to very expensive high tech intensive care facilities, successfully 
reduced their neonatal mortality rates
 [17].  
According to the March of Dimes 2009 Global Report on Preterm Births [18], there are huge gaps 
in  the  data with regards to preterm birth, prevalence, mortality, acute morbidity and long term 
impairment in low income countries. Such deficiencies in the available data makes the much needed 
systematic scaling up of neonatal care [20] in these countries an extremely difficult task. The present 
study aims to bridge this gap. We collected, analyzed and compared the gestational age specific 
mortality and morbidity data from the State of Qatar which has achieved excellent Neonatal mortality 
rates in recent years (4.37, 5.1, 4.4, and 4.0/1,000 births in 2006, 2007, 2008 and 2009   
respectively) [19,21,22] with the data from the developed countries. In addition, the current study also 
explored the feasibility of facility based cost effective options for saving babies at the lowest limits of 
viability (28
+1 to 32
+0 weeks) in low income countries. 
1.1. Aim of the Study 
The present study analyzed the gestational age specific mortality and morbidity outcome of 28
+1 to 
32
+0  weeks  gestation babies in the State of Qatar over a period of five  years (2002–2006),  and 
compared the outcomes with recent data published in the well established international neonatal 
databases from some high income countries (VON [23] and NICHD [24]) and recent studies published 
from UK [1], France [2] and Europe [3,4]. The six specific objectives of our study were to:  
•  Develop a Performa, using the international databases (VON and NICHD) as a template, in order 
to collect the mortality and pre discharge in hospital morbidity of 28
+1 to 32
+0 weeks gestation 
babies in the State of Qatar based on the individual patient medical records;  
•  Retrieve data on gestational age specific mortality and morbidity outcome of 28
+1 to 32
+0 weeks 
gestation babies in the State of Qatar for the period (2002–2006); (N = 597 during the study 
period); Int. J. Environ. Res. Public Health 2010, 7                 
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•  Double check the validity of the data collected via the Performa using parallel databases in our 
institution (Hamad Medical Corporation); 
•  Appraise the Qatari mortality and pre discharge in hospital morbidity data and compare the 
outcomes with similar data from VON, USA (NICHD), UK, France and Europe;  
•  Analyze the characteristics of respiratory support needed at each successive gestational week 
among our sample (28
+1 to 32
+0 weeks) and compare it with data from Vermont Oxford Network 
(2007) report; and, 
•  Contribute towards  finding  evidence based  cost effective  neonatal care options for resource 
restricted developing countries which are struggling to reduce their burden of neonatal mortality.  
2. Methods 
2.1. Procedures and Sample 
This retrospective analytic study was approved by the Institutional Research Board of Hamad 
Medical Corporation (protocol No. 7004/07), and undertaken in the Neonatal Intensive Care Unit 
Women’s Hospital in Doha (the only tertiary care maternity and neonatal unit in the State of Qatar). 
The Hospital was accredited in 2006 and re-accredited in 2009 by the Joint Commission International 
(JCI) USA for its Standards and Quality of Care. About 99% of deliveries in Qatar take place in this 
hospital. All inborn and out born babies delivered ≤32 week gestation in the State are admitted to the 
Women’s Hospital. Therefore the data with regards to ≤32 week gestation babies from our study not 
only accurately represents  Qatar’s national data, for all practical purposes, it is equivalent to a 
population-based study.  
2.2. Performa and Data Collection 
A standard Performa based on established international neonatal databases like VON and NICHD 
as well as some recently published preterm mortality and morbidity outcomes data from the high 
income countries [2-4,23,24] was developed by the authors. Using the standard Performa, data was 
collected by two of the authors (H.P, K.P.N) from individual patient medical records using anonymous 
identification numbers. Due to the retrospective medical records based nature of the study, individual 
patient consent was not required by the Institutional Research Board. The Performa comprised data 
items that included a range of base line characteristics of antenatal care (Table 1); the use of antenatal 
steroids, mode of delivery, condition at birth, and  respiratory management in the neonatal period 
(Table 2); mortality (Table 3); and, in hospital pre discharge morbidity in the survivors (Table 4). A 
Performa was completed for each of all 28
+1 to 32
+0 weeks gestation babies (N = 597) admitted during 
the study period (1st January 2002–31st December 2006). Twenty seven individual patient medical 
records (4.5%) were incomplete. This deficiency was completed from other parallel data bases (e.g., 
admissions, discharge and death registers of the neonatal unit). These parallel information sources 
were also used to double check the validity of the rest of the data.  
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2.3. Outcome Measures 
We employed three major categories of outcome measures: (1) 28
+1 to 32
+0 weeks gestation birth 
rates; (2) in hospital pre-discharge mortality (total and gestational age specific); and, (3) in hospital 
pre-discharge morbidity (CLD, NEC, Symptomatic PDA, IVH  Grade III and IV, Cystic PVL,  
ROP ≥ Stage 3). Chronic Lung Disease (CLD) was defined as supplemental oxygen dependence or 
ventilation including CPAP at 36 weeks corrected post-menstrual age (PMA). Neurologic morbidity 
(IVH and PVL) were defined using the Papile Classification [25]. We also analyzed the characteristics 
of respiratory support (e.g., MV, surfactant  therapy, CPAP therapy and total days on respiratory 
support) needed at each successive gestational week among our sample (28
+1 to 32
+0 weeks). The 
comparative data for Vermont Oxford Network (VON) was ascertained from its 2007 report available 
in CD format and on its web site (www.vtoxford.org) [23]. VON has two sections in its database: 
1. Low birth weight database (babies 501–1,500 grams at birth) 
2. Expanded database (babies of all birth weight and gestational ages) 
The expanded database classifies babies both according to the birth weight categories and 
gestational age categories. The gestational age category tables 19–32 of Expanded database in VON’s 
2007 report presents data according to the following gestational age categories irrespective of their 
birth weight; <27, 27–29, 30–32, 33–36, 37–41 and >41 weeks. We used the 30–32 weeks group from 
expanded database gestational age categories which is the best nearest to our data (28
+1 to 32
+0). 
VON’s 30–32 weeks group in the expanded database includes babies of all birth weights (<1,500 g and 
>1,500 g). This makes the comparative groups very similar to ours. In VON database the outcomes are 
described as percentage (%) with 1st and 3rd network quartile without giving the actual numbers (n) in 
any category. VON gives the total and group specific number (N) of babies in the beginning of each 
table. We calculated the n for each category of VON tables using the 19–32% and the total numbers 
(N) given in the beginning of each table. 
2.4. Statistical Analysis 
The net based statistical package Vassar stat was employed for data analysis. The chi square (χ
2) 
test was used to compare the Qatar data with that of VON and other high income countries. The 
significance level was set at p < 0.05.  
3. Results 
A total of 64,689 live births were recorded during the study period with 597 of these babies being 
babies between 28
+1 to 32
+0 weeks gestation, thus giving a prematurity rate of 9.23 per 1,000 total 
births for the target gestational age category during the study period. Our 28
+1 to 32
+0 weeks gestation 
prematurity rate was less than the rates for the same gestation group in the UK (p < 0.0001). Table 1 
highlights the patient characteristics of our sample in comparison to VON, which is an international 
database of more than 800 Neonatal ICU’s; more than 95% of which are located in North America, 
Western Europe and Australia. 86.44% of our babies had birth weights between 1,001 and 2,000 g and 
only 3.9% were SGA as compared to 12% in VON database (p < 0.0001). Singleton babies comprised 
81.91% of the sample. The gender distribution was equal, and almost 45% of the babies were born to Int. J. Environ. Res. Public Health 2010, 7                 
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native Qatari families and 55% to expatriate families living and working in Qatar. This is in line with 
the general distribution of population in Qatar [25]. The rate of antenatal steroid administration in our 
sample (86.1%) was better (p < 0.0001) than VON (73%). The 28
+1 to 32
+0 weeks mortality rate in our 
sample was 65.3/1,000, which was higher (p < 0.0001) than VON (29.9/1,000). 35.89% of deaths in 
our cohort were Early Neonatal Deaths (0–7 days of life) and 64.11% Late Neonatal Deaths (8–28 
days of life). Lethal Congenital and Chromosomal Anomalies accounted for  12  deaths  (30.77%); 
Trisomy  18 (four cases), Trisomy 13 (one case), multiple congenital anomalies (one case), and 
complex congenital heart disease (four cases including two with Down’s syndrome). 
Table 1. Comparison of patient characteristics between Qatar and  Vermont Oxford 
Network (VON). 
Characteristic  Qatari Sample N (%)  VON* N (%)  P –Value** 
Birth Weight (grams) 
<1,000 
1,001–1,500 
1,501–2,000 
>2,000 
 
19 (3.18) 
205 (34.34) 
311 (52.1) 
62 10. 38) 
 
— 
 
Gender 
Male 
Female 
 
295 (49.41) 
302 (50. 59) 
 
6,222 (54) 
5,301(46) 
 
Ethnicity 
Qatari 
Non Qatari 
 
269 (45.06) 
328 (54. 94) 
 
White 6,914(60) 
NonWhite 4,609(40) 
 
Plurality 
Singleton 
Twins (39 × 2) 
Triplets (10 × 3) 
 
489 (81. 91) 
78 (13.06) 
30 (5. 03) 
 
8,873 (77) 
1,613 (14) 
1,037(9) 
 
Intrauterine Growth 
SGA  
 
23(3. 9) 
 
1,383 (12) 
 
<0.0001 
Antenatal Steroids 
Yes 
 
514 (86.1) 
 
8,412 (73) 
 
<0.0001 
Caesarean Section 
Yes 
 
324 (54. 27) 
 
7,720 (67) 
 
<0.0001 
Respiratory Support 
Yes 
 
373 (62.48) 
 
— 
 
Surfactant Therapy 
Yes 
 
192 (32.16) 
 
4,312 (37.4) 
 
Symptomatic PDA 
Total 
Medical Treatment 
Surgical Treatment 
 
20 (3.35) 
16 (2.68) 
4 (0.67) 
 
1,498 (13) 
461 (4) 
 115 (1) 
 
ROP ≥ Stage 3 
Total 
Surgical Treatment 
 
34 (5.69) 
6 (1.0) 
 
115 (1) 
 0 (0) 
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Table 1. Cont. 
Mortality Rate/1000 
Total 
Early (<7d) 
As % of Total Mortality 
Late (>7d) 
As % of Total Mortality 
 
39 (65.3/1,000) 
14 (23.45/1,000) 
35. 89% 
25 (41.87/1,000) 
64.11% 
 
333 (29.9/1,000) 
 
<0.0001 
Causes of Mortality 
Lethal Congenital & 
Chromosomal Anomalies 
Sepsis 
Severe Birth Asphyxia 
NEC 
Pulmonary Hemorrhage 
Hydrops / Congenital Infection 
 
12 (30.77) 
 
11 (28.20) 
6 (15. 30) 
4 (10. 25) 
3 (7.69) 
3 (7.69) 
 
 
 
— 
 
Total Babies: Qatari Cohort (29–32 week) = 597, VON (30–32 weeks) = 11,523;  
* Data represents 30–32 weeks gestation group from Expanded data base VON 2007 report [23] 
** Chi Square test used to calculate p-value. 
Table 2. Characteristics of Respiratory Support in Qatar for 28
+1 to 32
+0 weeks gestation babies. 
GA: gestational age; RS: Respiratory Support; Surf: Surfactant therapy; MV: Mechanical Ventilation;  
CPAP: Continuous Positive Airway Pressure;  
* CPAP alone: 186 (31.1%) CPAP following MV: 83 (13.9% of total babies and 44.4% of babies requiring MV) 
** p-value calculated using the Chi Square test (comparing decreasing respiratory support with increasing GA). 
 
Table 2 shows the characteristics of the respiratory support required by the 28
+1 to 32
+0 weeks 
gestation babies of our cohort during their stay in the NICU. Slightly more than one third of our babies 
(37.52%, n =  224) did not require any respiratory support during their entire NICU stay. Of the 
remaining 373 babies (62.48%) who required respiratory support, 186 (31.3% of total and 50% of 
babies requiring respiratory support) needed CPAP alone. One hundred and eighty seven (31.3% of 
total and 50% of babies requiring respiratory support) needed MV. Among the babies requiring MV, 
83 (13.9% of total babies and 44.4% of babies requiring MV) needed post extubation CPAP support. 
Surfactant therapy was required only by one third (32.16%) of total babies. The need for respiratory 
support decreased (p < 0.001) with increasing gestational age (MV decreased from 88.71% at 29 
weeks to 13.26% at 32 weeks; CPAP decreased from 66.13% at 29 weeks to 31.44% at 32 weeks; and 
GA 
Weeks 
 N  RS 
n (%) 
Surf 
n (%) 
MV  
n (%) 
CPAP  
n (%)  
29  62  58 (93.55)  55 (88.71)  55 (88.71)  41 (66.13) 
30  116  95 (82.00)  42 (36.21)  48 (41.38)  63 (54.31) 
31  155  110 (71.0)  49 (31.61)  49 (31.61)  82 (52.9) 
32  264  110 (41.67)  41 (15.53)  35 (13. 26)  83 (31.44) 
Total  597  373 (62.48)  192 (32.16)  187 (31.32)  269 (45.06)* 
p Value**    <0.001  <0.001  <0.001  <0.001 Int. J. Environ. Res. Public Health 2010, 7                 
 
2533 
surfactant replacement decreased from 88.71% at 29 weeks to 15.53% at 32 weeks). Most of the 
respiratory support (80.12% MV, 96.28% CPAP) was required for short duration (<96 hours).  
Table 3 depicts the total and gestational age specific mortality and survival rates with a comparison 
with recent data from UK  [1]. Qatar’s average Neonatal Mortality Rates for the study period 
6.34/1,000 and 28
+1 to 32
+0 weeks gestation mortality rate was 65.33/1,000. Qatar’s 28
+1 to 32
+0 weeks 
gestation survival rate of 93.47% was significantly less (p < 0.0001) than the same gestational age 
survival rate in UK during 2006 [1]. Within our own cohort the gestational age specific survival rate 
increased significantly (p < 0.001) with every single week increase in gestational age (from 85.49% at 
29 weeks to 96.66% at 32 weeks).  
Table 3. Comparative analysis of total and gestational age specific mortality and survival 
rates: Qatar versus high income countries.  
 
Parameter 
Qatar  
(2002-6) 
UK 
(2006)
a 
P 
 Value 
Total Births  64,689  669,465   
Neonatal Mortality
b  410 (6.34/1,000)  2,305(3.44/1,000)   <0.0001 
Neonatal Survival (%)  99.4  99. 6   
Premature Births 
 
597 
(29–32 weeks) 
7,770* 
(29–32 weeks) 
 
Prematurity Rate 
(/1,000) 
9.23 
(29–32 weeks) 
11.6* 
(29–32 weeks) 
<0.0001 
29–32 Weeks gestation  
Total 
Mortality n (/1,000) 
Survival (%) 
 
597  
39(65.33) 
93.47 
 
7,770* 
189(24.32) 
97. 6 
 
 
<0.0001
 
29 Weeks gestation  
Total 
Mortality n (/1,000) 
Survival (%) 
 
62 
9(145.16) 
85.49 
 
1,243 
61(49.07) 
95.1 
 
 
<0.005 
30 Weeks gestation 
Total 
Mortality n (/1,000) 
Survival (%) 
 
116 
15(129. 31) 
87.07 
 
1,569 
52(33.14) 
96.7 
 
 
<0.0001 
31 Weeks gestation 
Total 
Mortality n (/1,000) 
Survival (%) 
 
155 
6(38.71) 
96.13 
 
2,066 
43(20.81) 
97. 9 
 
 
 =0.24 
32 Weeks gestation 
Total 
Mortality n (/1,000) 
Survival (%) 
 
264 
9(34. 09) 
96. 66 
 
2,892 
33(11.4) 
98. 9 
 
 
 =0.005 
a UK Office of National Statistics Bulletin Published May 28, 2009 [1]; (*calculated from the reference) 
b Qatar’s average NMR for 2002–2006. Qatar’s NMR for 2006 was 4.37/1,000.  Int. J. Environ. Res. Public Health 2010, 7                 
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Tables 4 illustrates the total and gestational age specific in hospital pre discharge morbidity of 28
+1 
to 32
+0 weeks gestation babies in Qatar with comparative figures for 30–32 weeks gestation babies 
from the expanded data base in VON 2007 report [23].  
Table 4. Total and gestational age specific in hospital pre discharge morbidity in Qatar 
compared with VON data (30–32 weeks).  
 
Gestation 
N  CLD  
n (%) 
PDA 
n (%) 
NEC 
n (%) 
IVH  
G-III 
n (%) 
IVH  
G-IV 
n (%) 
Cystic PVL 
n (%) 
ROP ≥Stage 3 
n (%) 
29 Weeks  62  5 (8.1)  5(8.06)  2(3.22)  3(4.81)  1 (1.61)  2(3.2)  11(17.74) 
30 Weeks  116  7 (6.0)  12(10.34)  7(6.03)  1 (0.86)  1 (0.86)  1(0.86)  8(6.89) 
31 Weeks  155  3 (1.94)  3(1.93)  4(2.58)  1 (0.65)  0  0  8(5.16) 
32 Weeks  264  1 (0.38)  0  2(0.75)  0  1(0.38)  0  7(2.65) 
Total  597  16 (2.68)  20(3.35)  15(2.51)  5(0.84)  3(0.5)  3(0.5)  34(5. 69) 
VON* 
p-value** 
1,1523  1,498(13%) 
<0.0001  
1,498(13%) 
<0.0001 
346(3%) 
 =0.57 
115(1%) 
 =0.86 
115(1%) 
 =0.32 
115(1%) 
 =0.32 
115(1%) 
<0.0001 
CLD: Chronic Lung Disease; PDA: Patent Ductus Arteriosus; NEC: Necrotizing Enterocolitis;  
IVH: Intraventricular Hemorrhage; G-III: Grade III; G-IV: Grade IV; PVL Periventricular Leukomalacia; 
ROP: Retinopathy of Prematurity; *VON report 2007 Data for 30–32 weeks gestation [23];  
**Chi Square was used to calculate p value.  
 
Our incidence of CLD and symptomatic PDA was significantly less (p  <  0.0001), while the 
incidences of NEC, IVH grade III, IVH grade IV and PVL were similar to VON. On the other hand, 
our incidence of ROP was significantly higher (p < 0.0001) than VON. Within our cohort the incidence 
of symptomatic PDA, NEC and ROP ( ≥ Stage 3) decreased with every single week increase in 
gestational age (p < 0.05).  
We constructed Table 5 using a subanalysis of our data restricted to babies with birth weight   
1,001–1,500 g (n = 282). This included 205 babies from our study, as shown in Table 1, plus 77 babies 
who were <28 weeks gestation from another yet unpublished study conducted for the same time period 
(2002–2006)  by our group on extremely low birth weight babies.  This  subanalysis  made it more 
rational for us to compare our pre-discharge in hospital morbidity outcome with studies based on birth 
weight instead of gestational age. Table 5 depicts comparative data for 1,001–1,500 g babies between 
Qatar and recent studies from the USA (NICHD) [24], Italy (Trento study) [30] and UAE [31]. The 
incidence of pre- discharge respiratory and neurologic morbidity was very low among our cohort as 
compared to NICHD, but comparable to the Trento and UAE studies. Severe ROP (≥Stage 3) was high 
(5.69%) in our study as compared to all the other groups.  Int. J. Environ. Res. Public Health 2010, 7                 
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Table 5. Comparative Analysis of in hospital pre discharge Morbidity Rates for   
1,001–1,500g birth weight babies: Qatar versus NICHD, Trento and UAE. 
 
Study 
N  CLD  
n (%) 
PDA 
n (%) 
NEC 
n (%) 
IVH G-3 
n (%) 
IVH G-4 
n (%) 
Cystic PVL 
n (%) 
ROP ≥Stage 3  
n (%) 
NICHD
24  9,841  * (10)  * (18)  —  * (5)   * (2)  * (1.5)   — 
Trento 
30  166  2 (1.2)  16 (9. 6)  1 (0.6)  2 (1.2)  3 (1.8)  4 (2.4)  0 (0) 
UAE
31  110  6 (5.5)  —  5 (4.5)  1 (1)  0 (0)  1 (1.1)  0 (0) 
QATAR**   282  15 (5. 3)  20 (7.1)  10 (3.5)  5 (1.8)  4 (1.4)  3 (1.1)  7 (2.5) 
NICHD: National Institute of Child Health and Human Development; UAE: United Arab Emirates;* Absolute 
numbers not provided in the NICHD Study; [24]; ** Sub analysis of our data restricted to babies with BW 
1,001–1,500 g (205 babies from our study plus 77 babies from < 28 weeks gestation cohort from another study 
undertaken by our group for the same time period 2002–2006). 
4. Discussion 
Progress in neonatology is generally portrayed as inexorable: doing better and better with smaller 
and smaller [10]. However, this represents only one side of the challenge, reflecting the outcome of 
only 1% of global births which take place in high income countries. Of the 130 million babies born 
every year worldwide, 12.9 million are born preterm. Four million babies die in the first month of life; 
and 99% of these deaths occur in low and middle income countries due to causes which are largely 
preventable [16]. Preterm mortality accounts for 28% of global neonatal deaths [16]; (about 1.12 
million deaths per year) [18]. This could possibly even be an under estimation because a large number 
of preterm births in low income countries take place in the community and are never reported [16]. 
Hence,  low income countries are caught between the dilemma of limited human and economic 
resources and the reports of increasingly intact survival of very preterm babies particularly those born 
at >28 weeks gestation and >1,000 g at birth [10-14]. The rapid and widespread use of information 
technology has raised parental expectations all over the world. The unfortunate fact is that the 
resources available are limited, particularly in developing countries,  and rationing is imperative. 
Therefore where and how to invest in neonatal care in low income countries remains a very important 
question [27].  
Among the low income countries, Sri Lanka stands out for having achieved a significant decline in 
its neonatal mortality rates by sustained investment in primary health care facilities and without 
establishing many high tech expensive neonatal intensive care units  [17]. However, any further 
reduction in neonatal mortality in low income countries, particularly among the preterm infants, will 
need some facility-based interventions.  Some low cost interventions like regular use of antenatal 
steroids for preterm labor and the increasing use of non invasive respiratory support in the neonatal 
units has contributed significantly to the survival of extremely preterm babies in high income 
countries. The application of these low cost interventions may increase the intact survival of preterm 
babies at the limit of viability in the low income countries (28
+1  to  32
+0  weeks  gestation) at an 
affordable cost. In order to explore this proposition, we carried out this analytic and comparative study 
of the outcome of 28
+1 to 32
+0 weeks gestation babies in the State of Qatar. The selection of Qatar is a 
model of study was based on two rationale: first, the Perinatal and Neonatal survival rates in Qatar 
have significantly improved over the last thirty years to the extent that its current rates are comparable Int. J. Environ. Res. Public Health 2010, 7                 
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to many high income countries [19,21,22]; and second, the population of Qatar displays great diversity 
in its genetic, cultural and social backgrounds. Almost 60% of the resident families are economic 
migrants, mostly from Middle East, South and South East Asia [26]. Since the State of Qatar provides 
equal access to health care for its residents, both local and expatriate, the outcomes are even among a 
population with diverse origins [26]. In other words if a similar level of care is provided in the native 
countries of expatriate residents, the outcomes would be equally good.  
We conducted the current study with six very clear objectives described in the methodology 
section. The first three objectives were successfully met by developing a standard Performa based on 
international benchmarks [23,24] followed by its testing and validation using parallel data bases in  
our unit.  
To meet the fourth objective of our study, we tabulated the characteristics of our patient population 
(Table 1) in comparison to similar characteristics employed in VON [23]. There was no difference in 
the sex distribution and plurality between our data and VON. The number of babies with intrauterine 
growth retardation (SGA) was very high (p < 0.0001) in VON (12%) as compared to Qatar (3.9%). 
The case (p  <  0.0001)  for babies delivered by caesarean  section (67%  vs.  54.27%)  was similar. 
Intrauterine growth retardation provides a respiratory advantage in the immediate postnatal period 
because the incidence and severity of surfactant deficiency lung disease is less in Small for Gestational 
Age (SGA) babies which comprise a significant proportion of the births in the low income countries. 
According to our study, the birth rate of 28
+1 to 32
+0 weeks gestation babies in Qatar is 9.23/1,000 
which is significantly less (p < 0.0001) than the rate of similar gestation babies from UK (11.6/1,000) [1], 
but significantly higher (p < 0.0001) as compared to the rate of 7.6/1,000 in France [3,4]. The assisted 
reproductive unit in Qatar was established in the mid 1990s. Since then the number of preterm as well 
as multiple births have gradually increased in the State. Approximately 97% of babies in our cohort 
were >1,000 g at birth; thus making it feasible to compare with some reports based on birth weight 
rather than gestational age.  
We assessed our data (Tables 2, 3 and 4) for the three outcome measures (mortality, morbidity and 
requirements for respiratory support in the immediate postnatal period) and compared the outcomes 
with similar data from, UK [1], Europe [2], France [3,4], USA [24], Italy [30] and UAE [31].  
Mortality:  Qatar’s average NMR for the study period (2002–2006) was 6.34/1000,  which was 
significantly higher (p < 0.001) than UK’s NMR in 2006 (3.4/1,000) [1]. However, year by year, 
Qatar’s NMR decreased significantly from 7.49/1,000 in 2002 and 8.49/1,000 in 2003 to 4.37/1,000 in 
2006. Qatar’s 2006 NMR was comparable to UK’s 2006 NMR (p = 0.08). Qatar’s average survival 
rate of 28
+1 to 32
+0 weeks gestation babies during the study period (2002 to 2006) was 93.47%, which 
is very close to the rate in Europe (94.8%)  [2]  and France (95.36%) [3,4]  but  significantly  less  
(p < 0.0001) than the 2006 rate in the UK (97.6%)[1] . Lethal congenital and chromosomal anomalies 
were the leading cause (31%) of death in our Qatari cohort. This might not be very surprising, as 
according to the March of Dimes Birth Defects Foundation Report published in 2006 [28], Arab 
countries have the highest incidence of birth defects in the world. The incidence of birth defects in 
Qatar is 73.4 per one thousand live births [28]
 which is very similar to other Arabian Gulf countries. 
The overall consanguinity rate in the Arab world ranges between 40 and 70% while Qatar’s 
consanguinity rate is (54%) [29]. At the same time, Qatar has a very low elective antenatal termination 
rate due to socio cultural and religious reasons. Collectively these factors have resulted in a very high Int. J. Environ. Res. Public Health 2010, 7                 
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birth defects rate in Qatar. Among European countries the rate of elective terminations for congenital 
anomalies varies from 0.5% in Poland to 14.6% in Italy and 17.6% in France  [3].  An improved 
antenatal termination rate may help in reducing  neonatal deaths due to lethal congenital and 
chromosomal anomalies in Qatar. Qatar’s 28
+1 to 32
+0 weeks survival rate was very close to that of 
Europe (94.8%) [2] and France (95.3%) [3,4]. The French study [3,4] excluded congenital anomalies 
from outcome data. A head to head analysis between Qatar and France, after excluding congenital 
anomalies in both the data sets, reveals a better outcome of 28
+1 to 32
+0 weeks gestation babies in 
Qatar. The survival rate of 28
+1 to 32
+0 weeks gestation babies in our study increased (p < 0.001) with 
increasing gestational age (from 85.94% at 29 weeks to 96.66% at 32 weeks); a trend similar to the 
patterns witnessed in the UK [1] and France [3,4]. 
Morbidity: The incidence of in hospital pre discharge morbidity (Table 4) of our cohort was better 
than VON [23] (symptomatic PDA 3.35% (p < 0.0001), NEC 2.51% (p = 0.057), IVH Grade III 0.84% 
(p = 0.086), Grade IV 0.5% (p = 0.032) and cystic PVL 0.5% (p = 0.032)). The incidence of CLD was 
significantly higher (p < 0.0001) in VON as compared to Qatar (10% versus 2.68%). According to the 
2007 report of VON [23], 40% of babies born at gestational age between 30 and 32 weeks required 
MV, 60.57% required CPAP, while 39% were given surfactant. It is possible that the high rate of use 
of antenatal steroids in Qatari cohort (86.1% vs. 73% in VON p < 0.0001) and the fact that 69% of 
babies in qatari cohort required either no respiratory support or only short term CPAP may have 
contributed toward a significantly low incidence of CLD among 28
+1 to 32
+0 weeks gestation babies Qatar. 
Qatar’s higher mortality gestational age specific mortality rates during the study period may have 
lowered the rates of morbidities. In this study we had also analyzed the week wise mortality for each 
individual year from 2002 to 2006. The gestational age specific mortality decreased significantly in 
each group between 2002 and 2006. Qatar’s 2006 gestational age specific mortality and morbidities 
remain comparable to most of the international benchmarks.  
We undertook a sub analysis for birth weight specific (1,001 to 1,500 g) morbidity outcomes in our 
cohort and compared our findings (Table 5) with the recently published NICHD data [24], the Trento 
Study from Italy [30] and a study from the United Arab Emirates [31]. Our rate of CLD was better 
than NICHD [24], comparable to UAE [31] and more than Trento [30]. While our rates of IVH grade 
III, grade IV and PVL were similar to other studies, the rates of NEC and ROP ( ≥Stage 3) were much 
higher than these studies. This suggests the need for further research into our very low birth weight 
feeding practices and oxygen saturation monitoring policies. Although 20 (3.35%) babies in Qatari 
cohort had hemodynamically significant PDA, only four babies (0.67%) required surgical ligation. 
Similarly, 34 (5.69%) babies in the Qatari cohort had ROP (≥Stage 3) but only six babies (1.0%) 
required laser therapy. The incidence of ROP decreased with increasing gestational age (11.74% at 29 
weeks to 2.65% at 32 weeks). This decrease is in agreement with the pattern and intensity of 
respiratory support and hence use of supplementary oxygen which decreased with increasing 
gestational age. A similar pattern was also observed in a recent study of low birth weight babies from 
UAE [31].  
Patterns of Respiratory support: For the fifth objective, in addition to analyzing the patterns of 
respiratory support we also analyzed the implications of our findings for low income countries in terms 
of cost and feasibility.  Respiratory support, the immediate postnatal requirement of most preterm 
babies, has significantly changed its pattern over the last decade with marked reduction in the Int. J. Environ. Res. Public Health 2010, 7                 
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requirement of mechanical ventilation [32]. The change, which is particularly marked in babies  ≥ 29 
weeks gestation [32], may be a blessing for low income countries because the number of care days 
required by the ventilated babies is a major expense in the NICU [10]. In our cohort of 28
+1 to 32
+0 
weeks gestation babies in Qatar, slightly more than one third of the total babies (37.5%) did not require 
any respiratory support while another one third of the total babies (31.1%) required short term   
(<96 hours) non invasive respiratory support with CPAP. The number of babies requiring CPAP 
decreased sharply with increasing gestational age (p < 0.001) and increasing post natal age (p < 0.001). 
Of the babies who required CPAP in our cohort, 55% required CPAP for <24 hours while another 40% 
required CPAP between 24 and 96 hours of age. Over the last decade not only the knowledge and 
practice of using CPAP and its variants in NICUs has tremendously increased with significant 
reduction in the need of intubated respiratory support [32,33]; but also low cost CPAP modalities have 
been introduced for developing countries [34]. The recently published experience of using low cost 
Bubble-CPAP in Fiji is very encouraging [34]. These changing patterns of respiratory support and 
innovation in CPAP therapy makes it possible to save the majority of the 28
+1 to 32
+0 weeks gestation 
babies in low resource countries without restoring to high cost MV and surfactant replacement therapy. 
In our cohort only one third of total babies (31%) required short term (<96 hours) MV and 32% of the 
total babies required surfactant replacement therapy. Some of the babies in our cohort were intubated, 
given surfactant and extubated to CPAP (INSURE therapy); hence the number of babies requiring 
surfactant is more than the babies given MV. The requirement for MV, in our cohort, decreased 
sharply with increasing gestational age and postnatal age (p < 0.001). Antenatal steroids enhance the 
foetal “lung maturation” by increasing the surfactant production and release; thus reducing the need of 
respiratory support in the immediate postnatal period with improvement in survival of preterm   
infants [32]. Our very good rate of antenatal steroid administration (86.1% as compared to 73% in 
VON) and 100% surfactant replacement therapy in ventilated babies may have contributed 
significantly towards short term (<96 hours) gentle ventilation in the immediate postnatal periods as 
well as to the low incidence of CLD (2.68%) in our cohort.  
Our data is stratified according to gestational age which is a better indicator of maturity, though 
most of the publications and some standard neonatal databases (e.g., NICHD) are stratified according 
to the birth weight  [24]. VON data is stratified both according to the gestational age and birth   
weight [23]. Due to these different stratification methods, it was difficult for us to generate a head to 
head comparison with other studies including VON in which the gestational age stratification group 
(30–32 weeks) was more closer to ours (28
+1 to 32
+0 weeks). However, as shown in Tables 4 and 5, the 
general patterns of mortality and incidence of in hospital pre-discharge morbidities are similar between 
these data bases and our study. The recently published birth weight stratified data from Italy [30] and 
UAE [31] have shown a lower incidence of in hospital pre discharge morbidity as compared to VON. 
Our morbidity pattern was similar to the study from Italy [30] and UAE [31]. A recent review of 
NICHD data base has found a wide range of morbidity and mortality among network centres [24]. A 
similar variation was reported by the MOSAIC study data base from 10 different European regions [3,4]. 
This indicates that some best practices and currently available therapies are awaiting a formal 
discovery [24] which may help change the fate of millions of babies in the low income countries [35]. 
For the sixth objective, driven by Qatari data, we tried to find evidence on how and where to invest 
in neonatal care in low income countries to reduce the burden of four million total and 1.12 million Int. J. Environ. Res. Public Health 2010, 7                 
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preterm neonatal deaths; a major challenge faced by Perinatal health care planners [17,27]. A point to 
note is that  major reductions  in neonatal mortality can be achieved, within resource restricted 
environments, by sustained input at the community and primary health care level which must stay as 
the highest priority. Sri Lanka, Vietnam, Indonesia, Honduras, Moldova and Nicaragua are low income 
countries with stories of success [17]
 in achieving significant reduction in neonatal mortality rates in 
resource restricted settings. For low income countries, the lower limit of viability should stay at 28 
weeks of gestation and 1,000 g birth weight as accepted by the UNICEF [19]. The experience from 
Qatar, to which our study is evidence, demonstrates that excellent preterm survival rates with 
minimum morbidity, comparable to high income countries are achievable. With limited resources, the 
facility-based services required for the care of preterm babies will have to be scaled up. Our study 
demonstrated that the vast majority of babies at the limit of viability for low income countries (28
+1 to 
32
+0 weeks gestation) can be saved by using low cost techniques including extensive use of antenatal 
steroids and post natal CPAP therapy which, of course will remain complementary to the basic needs 
of temperature maintenance, nutrition including breast feeding, and prevention and management of 
infection [20,35].  
5. Conclusions 
The State of Qatar has achieved an excellent rate of intact survival of 28
+1 to 32
+0 weeks gestation 
babies which is comparable to that of many high income countries. Qatar’s data demonstrates that low 
cost techniques (antenatal steroids for preterm labor  and post natal use of CPAP therapy), can 
potentially save the majority of 28
+1 to 32
+0 weeks gestation babies in low income countries with 
minimum in hospital pre discharge morbidity. The assessment of long term morbidities (at two years 
neurodevelopmental follow up) will be the true determinant of the ultimate outcome. Further, up to 
date studies in this area will be helpful for prioritizing health care investments in resource   
constrained countries.  
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